Kefi Gold & Copper Share News (KEFI)

Shares in Pangea DiamondFields jumped after the firm, which mines for the gemstones in Angola, said a recent sale of 1,964 carats yielded an average price of $147.50 a carat.The price represents 82% of the company's target of $180, but is well ahead of the 70% it had budgeted.Printed products group 4imprint posted a 3% fall in sales to £41.16m in the quarter to 26 September as customers cut back to save cash, but said October sales and order inflows were 'modestly encouraging.'Anglo Eastern Plantations, which produces palm oil in Indonesia, said it was encouraged by an improvement in prices for the commodity over the past three months and that it had lifted production.However, it added: 'Although production has grown as planned and commodity prices have remained generally stable throughout the period, the global recessionary market sentiment does create some uncertainty going forward.'European Goldfields, which mines and explores for metals in Greece and Romania fell into losses in the quarter to September 30 as revenues slipped.Pre-tax losses totalled $1.3m, compared with a profit of $242,000 over the same period the previous year, as sales fell to $17m from $18.4m.Shares in Kefi Minerals advanced after the gold and copper explorer said it had signed a letter of intent with Toronto Stock Exchange-listed Centerra Gold for a joint venture in the Bakir Tepe project in southwest Turkey.Drug developer Antisoma said it expects the first data from its phase II trial of its AS1411 treatment for renal cancer and additional details of Novartis's plans for developing 'potential blockbuster' ASA404 by the end of the year. Chief executive officer Glyn Edwards said at the company's annual general meeting that Antisoma is 'finishing 2009 in a strong position, with two drugs well into pivotal phase III trials and significant cash resources.'